Signal Advisors Wealth »

Intellia Therapeutics shares owned by Signal Advisors Wealth

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Signal Advisors Wealth from 13F filings

Historical chart of Signal Advisors Wealth investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Signal Advisors Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Signal Advisors Wealth

Quarter filed Position value Share count Share price at filing
2025-03-31 $552k 77k 7.12
2024-12-31 $865k 74k 11.66
2024-09-30 $953k 46k 20.55

More positions owned by Signal Advisors Wealth

Spdr Series Trust State Street Spd (SPLG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Bny Mellon Etf Trust Core Bond Etf (BKAG)
NVIDIA Corporation (NVDA)
Etf Ser Solutions Aptus Defined (DRSK)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Etf Ser Solutions Aptus Enhanced (JUCY)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Select Sector Spdr Tr State Street Tec (XLK)

View all positions for Signal Advisors Wealth

Top funds holding Intellia Therapeutics

Vanguard Group
ARK Investment Management
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Nikko Asset Management Americas
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Two Sigma Advisers
FMR

View all funds holding Intellia Therapeutics